TRABECTOME FOR MINIMALLY INVASIVE GLAUCOMA TREATMENT
Traditional glaucoma procedures include multi-drug approaches, lasers, eyedrops and even surgical interventions with unpredictable outcomes. Trabectome is different. Taking a cue from nature, Trabectome works to help the body help itself. Designed to improve fluid drainage from the eye and balance intraocular pressure, this minimally invasive procedure stabilizes optic nerve health to minimize further visual field damage.
Trabectome is an FDA-cleared device for minimally invasive surgical treatment of open angle glaucoma. It safely ablates and removes a 60°-120° strip of trabecular meshwork using a focused electrosurgical pulse and re-establishes access to the eye’s natural drainage pathway. Glaucoma surgeons across the United States and internationally have successfully used Trabectome on hundreds of patients since 2004.
•Low patient risk
•Simpler than traditional therapies
•Low complication rate
•Easily combines with cataract extraction
•Safe, economical and effective
Trabectome Removal of TM on Autopsy Eye: Collector channel, outer wall of Schlemm's canal. Ostium is intact, allowing aqueous free access to episcleral vessels. (Images and descriptions from Douglas Johnson, MD)